skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 200564 Find in a Library
Title: Biological Treatment of Dangerous Sexual Offenders: A Review and Preliminary Report of the Oregon Pilot depo-Provera Program
Journal: Aggression and Violent Behavior  Volume:8  Issue:4  Dated:July-August 2003  Pages:391-412
Author(s): Barry M. Maletzky; Gary Field
Date Published: July 2003
Page Count: 22
Type: Research (Applied/Empirical)
Format: Article
Language: English
Country: United States of America
Annotation: This article reviews the literature pertaining to the use of medications to reduce the sex drive of male sexual offenders and reports on the preliminary findings from an Oregon pilot depo-Provera program.
Abstract: Cognitive and behavioral treatment programs for sexual offenders have become widespread during the past 10 years. Despite the proliferation of treatment programs and the advances made in the treatment of sexual offenders, many of these offenders remain a danger to society. As such, interest has peaked in medical approaches designed to reduce the risk posed by such offenders. The United States has historically shied away from the medical castration that is used in many European countries. Instead, the use of medications to reduce sex drive has been championed by many as a viable option, coupled with the continued use of cognitive and behavioral therapies. The authors review the current research literature pertaining to the use of three classes of drugs used to hamper the sex drive of male sexual offenders: (1) hormonal agents that act peripherally, such as depo-Provera, (2) hormonal agents that act centrally, such as Leupron, and (3) serotonin-active antidepressants, such as Prozac and Paxil. Also reviewed are the preliminary findings from an Oregon pilot program utilizing depo-Provera in a group of potentially dangerous sexual offenders. Findings basically show that it is too soon to ascertain whether medication will help reduce sexual recidivism among those enrolled in the program. Thus far, medication has not been shown to increase compliance with the supervision requirements of these offenders. In conclusion, the authors note that medications should be seen as temporary solutions while offenders continue to undergo cognitive and behavioral treatments. References
Main Term(s): Sex offender treatment
Index Term(s): Biological influences; Literature reviews; Medical model of offender treatment
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.